Edgewise Therapeutics Inc (EWTX)

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	2.63% 34.75	33.86	29.45	25.34	25.70
Operating Income/Loss	2.63% -34.75	-33.86	-29.45	-25.34	-25.70
Income/Loss From Continuing Operations Before Tax	5.37% -28.52	-30.14	-25.71	-21.47	-22.84
Income/Loss From Continuing Operations After Tax	5.37% -28.52	-30.14	-25.71	-21.47	-22.84
Net Income/Loss	5.37% -28.52	-30.14	-25.71	-21.47	-22.84
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	24,620% 87.57	0.3542	63.46	63.38	63.27
Diluted Average Shares	24,620% 87.57	0.3542	63.46	63.38	63.27
Basic Earnings Per Share	29.79% -0.33	-0.47	-0.41	-0.34	-0.36
Diluted Earnings Per Share	29.79% -0.33	-0.47	-0.41	-0.34	-0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-